Pharma Focus Europe
Latest Issue
Get instant access to latest e-book

LATEST NEWS


Jun 2023

Single Cell Discoveries Procures Illumina NovaSeq X Plus, Making History in the Benelux Region

Single Cell Discoveries a Contract Research Organization CRO specializing in singlecell sequencing has proudly announced the introduction of the Illumina NovaSeq X Plus sequencing system in the Benelux region This marks a significant achievement for Single Cell Discoveries as they strive to drive in...


Jun 2023

FDA Grants Fast Track Designation to SAR'579 / IPH6101 for the Treatment of Hematological Malignancies

Innate Pharma SA Euronext Paris IPH Nasdaq IPHA is pleased to announce that the US Food and Drug Administration FDA has granted Fast Track Designation for SARIPH a potential treatment for hematological malignancies Fast Track Designation is a process established by the FDA to expedite the developmen...


Jun 2023

ACROBiosystems Enhances Custom GMP Grade Protein Services with Expanded Offerings

ACROBiosystems is a reputable company in the field of cell and gene therapy CGT providing a comprehensive range of services to support the commercialization of these advanced therapies CGT involves enhancing the immune system to combat cancer by infusing stem cells or modified immune cells and manuf...


Jun 2023

Emergex Announces Encouraging Phase I Trial Findings for DengueTcP™, an Innovative T Cell-Priming Immune Set-Point Candidate

Emergex Vaccines Holding Limited a clinicalstage biotechnology company has reported positive outcomes from its initial clinical trial of DengueTcP a candidate aimed at combatting the Dengue virus and Dengue Fever


Jun 2023

Amphera's MesoPher Receives Positive Opinion from European Medicines Agency for Orphan Medicinal Product Designation in Pancreatic Cancer

Amphera BV a biotechnology company in the late stages of development has made an announcement regarding its cell therapy called MesoPher The Committee for Orphan Medicinal Products COMP of the European Medicines Agency EMA has recommended granting orphan medicinal product designation for MesoPher in...


Jun 2023

ANeuroTech's ANT-01, an Adjunctive Anti-Depression Drug, Receives FDA IND Approval for Pivotal Phase IIIB Trial

ANeuroTech a pioneering company in the field of mental health treatments with minimal or no side effects has received approval from the US Food and Drug Administration FDA to begin a pivotal Phase IIIB trial of their drug ANT This trial will investigate the potential of ANT as an adjunctive treatmen...

press releases

Axol Bioscience Collaborates With StrataStem to Deliver Stem Cell Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

Axol Bioscience Ltd Axol a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimers Disease AD patient samples Harnessing its stem cell expertise Axol will reprogram these...

Productlife Group Announces Its Intention To Merge With Pharma D&s Group, Expanding Its Global Offer And Its Presence In Italy

ProductLife Group takes a key step in its growth with the acquisition of private Italian company Pharma DS Group Through this strategic alliance PLG a global provider of regulatory and compliance services for the life sciences industry strengthens its ability to enter the Italian market with its cor...

Curasight A/S reports positive preclinical results with uTREAT[®] in aggressive brain cancer (glioblastoma)

Curasight AS Curasight or the Company TICKER CURAS is pleased to announce preclinical data demonstrating the effectiveness of uTREAT in treating aggressive brain cancer glioblastoma The results from the study validate Curasights strategic focus on developing uTREAT as a viable treatment option for...

Digital Science boosts pharma industry support following OntoChem acquisition

Digital Science is positioning itself to play an even greater role in the pharmaceutical industrys allimportant drug discovery by helping industry sift through a sea of information and focus on the research that matters

12 - 13

Jun 2023

12 - 13

Jun 2023

13 - 15

Jun 2023

FCE Pharma – International

Sao Paulo, Latin America

14 - 15

Jun 2023

RNA Therapeutics USA

San Diego, CA, USA

19 - 21

Jun 2023


Shanghai, China

20 - 21

Jun 2023

Canna Pharma 2023

Philadelphia, United States

12 - 14

Jul 2023

CPHI South East Asia

Bangkok, Thailand

30 - 01

Aug 2023

CPHI Korea

Seoul, South Korea

PreAnalytiX - RNA Integrity
Selangor International Expo MEDIC 2023
3rd Annual mRNA-Based Therapeutics Summit 2023
Sartorius - Octet® Label-Free Promotional Bundle


  • 3

    Plant-derived Edible Nanoparticles in Delivering Cancer Drugs: Fact or Fad?

    Ryan Varghese

    Student and Researcher, Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth University.

    Abha Deshpande

    Poona College of Pharmacy, Bharati Vidyapeeth University

    Jainam Karsiya

    Clinical Pharmacist and Medical Affairs Executive,River Route Creative Group LLP

    Dileep Kumar

    Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University; Department of Entomology, University of California; UC Davis Comprehensive Cancer Center, University of California.

  • 5

    Therapeutic Intervention of Polymeric Nanoparticles Combining Bone Marrow Stem Cells for the treatment of Alzheimer’s disease

    Ruchi Chawla

    Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), India

    Varsha Rani

    Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), India

    Mohini Misra

    Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), India

    Krishan Kumar

    Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), India